Nora Perkins, MD
Otolaryngology · Albany, NYNPI 1760641096
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $259,720 of the $299,935 with a category attached, or 86.6%. Stryker accounts for 79.9% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2019 at $88,283 and has fallen 56.2% since, to $38,697 in 2025. Among otolaryngology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 429 payments — averaging $699.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$240K
- Aerin Medical Inc.$48K
- Sanofi$10K
- Regeneron Healthcare Solutions, Inc.$343
- GSK$248
- Jazz Pharmaceuticals Inc.$225
- plus $2K from 23 others
Across 2 payments — averaging $7492.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Spirair, Inc.$15K
What the payments were for
- Consulting fees$259,72087%
- Travel & lodging$28,0099%
- Food & beverage$12,2064%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 232 | $239,703 |
| Aerin Medical Inc. | 69 | $47,830 |
| Sanofi | 20 | $9,509 |
| Regeneron Healthcare Solutions, Inc. | 13 | $343 |
| GSK | 12 | $248 |
| Jazz Pharmaceuticals Inc. | 11 | $225 |
| CSL Behring | 10 | $200 |
| Intersect ENT, Inc. | 3 | $195 |
| Acclarent, Inc | 6 | $178 |
| Neurent Medical Limited | 3 | $159 |
| Spirair, Inc. | 1 | $133 |
| Harmony Biosciences LLC | 4 | $123 |
| Biosense Webster, Inc. | 1 | $122 |
| AstraZeneca | 6 | $112 |
| Novartis | 4 | $103 |
| Medtronic | 2 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $95 |
| Grifols USA, LLC | 5 | $92 |
| Amgen | 3 | $84 |
| Optinose US, Inc. | 4 | $78 |
| Johnson & Johnson(2 entities) | 2 | $72 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Alk-abello, Inc | 3 | $47 |
| Pfizer | 2 | $39 |
| Kaleo, Inc. | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| KARL Storz Endoscopy-america | 1 | $16 |
| Merck | 1 | $15 |
| Shire North American Group Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENTELLUS - XPRESS ENT DILATION SYSTEM$106,643
- LATERA$78,927
- XPRESS ENT DILATION SYSTEM$71,721
- CLARIFIX CRYOTHERAPY DEVICE$66,232
- SCOPIS ENT$62,812
- VIVAER STYLUS$46,722
- SHAVER SYSTEM$23,275
- TGS GUIDEWIRE$18,113
- XPRESS LOPROFILE$16,125
- CLARIFIX$14,450
- SURPASS EVOLVE$8,250
- 1688$8,250
- HEMOPORE$2,125
- RHINAER STYLUS$2,013
- DUPIXENT$1,218
- ORTHOMAP$1,125
- MINIFESS$531
- SPIROX - LATERA$396
- SeptAlign$266
- ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM$173
How this compares
$299,935 in reported general payments places this provider in the 95th percentile of 701 otolaryngology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 22 | $81,607 |
| Budesonide | 46 | $7,544 |
| Mometasone Furoate | 49 | $6,988 |
| Ipratropium Bromide | 143 | $6,016 |
| Qvar RedihalerBeclomethasone Dipropionate | 13 | $3,760 |
| Azelastine Hcl | 135 | $3,577 |
| Fluticasone Propionate | 100 | $3,495 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 21 | $3,316 |
| Famotidine | 214 | $3,070 |
| Omeprazole | 115 | $1,548 |
| Dexamethasone Sodium Phosphate | 23 | $1,473 |
| Levocetirizine Dihydrochloride | 57 | $1,079 |
| Ofloxacin | 16 | $1,022 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 24 | $961 |
| Montelukast Sodium | 105 | $948 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Albany
- Gavin SetzenAlbany$243K
- Robert KellmanSyracuse$2.5M
- Roheen RaithathaNew York$830K
- Moshe EphratNew Hyde Park$250K
- Habibullah JamalRye Brook$179K
- Albert JenFlushing$171K
- Dennis KrausNew York$159K
- Nitin BhatiaWhite Plains$120K
- Sveta KarelskyRochester$101K
- Anthony DelsignoreNew York$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.